http://www.cancercompass.comCancerCompass is an online community committed to offering people living with cancer a place to receive cancer information and news, share knowledge, and share cancer treatment experiences. To learn more, visit our site today.en-us@copy; Copyright 2008, International Capital & Management Company, LLLP. All Rights Reserved.Thu, 24 Jul 2008 00:32:42 CDTThu, 24 Jul 2008 00:32:42 CDTCancercompass.com: gynecological cancer60http://www.cancercompass.com/graphics/mini-logo.gifhttp://www.cancercompass.comhttp://www.cancercompass.com/cancer-news/1,14496,00.htm?rss=yhttp://www.cancercompass.com/cancer-news/1,14496,00.htm?rss=y Current study results from the report, 'Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial,' have been published. According to recent research from the United States, "Cancer diagnosis and treatment imparts chronic stressors affecting quality of life (QOL) and basic physiology. However, the capacity to increase survival by improving QOL is controversial." "Patients with cervical cancer, in particular, have severely compromised QOL, providing a population well-suited for the evaluation of novel psychosocial interventions and the exploration of mechanisms by which modulation of the psychoneuroimmune axis might result in improved clinical outcomes. A randomized clinical trial was conducted in cervic...Mon, 21 Jul 2008 00:00:00 CDThttp://www.cancercompass.com/cancer-news/1,14445,00.htm?rss=yhttp://www.cancercompass.com/cancer-news/1,14445,00.htm?rss=y Los Angeles, London, New Delhi, and Singapore -- Ground-breaking research in the June issue of Integrative Cancer Therapies published by SAGE explored whether ovarian cancer has a scent different from other cancers and whether working dogs could be taught to distinguish it in its different stages. Ovarian cancer has a high mortality rate, primarily due to late diagnosis. Recent studies have shown that dogs have successfully detected cancer through scent, however, it's not clear whether they're responding to the cancer itself or odors associated with cancer. The researchers, led by Gyorgy Horvath MD, PhD, from the University Hospital in Goteborg, Sweden, along with colleagues at Working Dog Clubs in Sweden and Hungary, trained dogs to...Fri, 04 Jul 2008 00:00:00 CDThttp://www.cancercompass.com/cancer-news/1,14435,00.htm?rss=yhttp://www.cancercompass.com/cancer-news/1,14435,00.htm?rss=y Combined positron emission tomography (PET) and computed tomography (CT) scanning of patients in the early stages of ovarian cancer can enable physicians to determine whether the cancer has spread to nearby lymph nodes without having to perform surgery, according to researchers at the SNM's 55th Annual Meeting. As a result, unnecessary surgeries could be reduced, which would also lower morbidity rates and postoperative complications for ovarian cancer patients. "Our preliminary research indicates that using PET/CT scanning in this way could greatly improve quality of life for many patients with ovarian cancer," said Luca Guerra, doctor of nuclear medicine, San Gerardo Hospital, Monza, Italy, and lead researcher of the study, 18F-FDG PET/...Fri, 04 Jul 2008 00:00:00 CDThttp://www.cancercompass.com/cancer-news/1,14434,00.htm?rss=yhttp://www.cancercompass.com/cancer-news/1,14434,00.htm?rss=y Women's reports of persistent, recent-onset symptoms linked to ovarian cancer -- abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating -- when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER. Research has found that when used alone, a simple four-question symptom-screening questionnaire and the CA125 ovarian-cancer blood test each detect about 60 percent of women with early-stage ovarian cancer and 80 percent of those with late-stage disease. This study found that when used together, the questionnaire and blood test may boost early-dete...Fri, 04 Jul 2008 00:00:00 CDThttp://www.cancercompass.com/cancer-news/1,14403,00.htm?rss=yhttp://www.cancercompass.com/cancer-news/1,14403,00.htm?rss=y Combined positron emission tomography (PET) and computed tomography (CT) scanning of patients in the early stages of ovarian cancer can enable physicians to determine whether the cancer has spread to nearby lymph nodes without having to perform surgery, according to researchers at the SNM's 55th Annual Meeting. As a result, unnecessary surgeries could be reduced, which would also lower morbidity rates and postoperative complications for ovarian cancer patients. "Our preliminary research indicates that using PET/CT scanning in this way could greatly improve quality of life for many patients with ovarian cancer," said Luca Guerra, doctor of nuclear medicine, San Gerardo Hospital, Monza, Italy, and lead researcher of the study, 18F-FDG PET/...Fri, 27 Jun 2008 00:00:00 CDThttp://www.cancercompass.com/cancer-news/1,14401,00.htm?rss=yhttp://www.cancercompass.com/cancer-news/1,14401,00.htm?rss=y SEATTLE -- Women's reports of persistent, recent-onset symptoms linked to ovarian cancer -- abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating -- when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER. Research has found that when used alone, a simple four-question symptom-screening questionnaire and the CA125 ovarian-cancer blood test each detect about 60 percent of women with early-stage ovarian cancer and 80 percent of those with late-stage disease. This study found that when used together, the questionnaire and bl...Tue, 24 Jun 2008 00:00:00 CDT